4//SEC Filing
Beneski Benjamin Machinas 4
Accession 0001737287-25-000026
CIK 0001737287other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:11 PM ET
Size
6.7 KB
Accession
0001737287-25-000026
Insider Transaction Report
Form 4
Beneski Benjamin Machinas
SVP, Chief Technical Officer
Transactions
- Award
Common Stock
2025-03-01+31,755→ 223,995 total - Award
Stock Option (Right to buy)
2025-03-01+112,339→ 112,339 totalExercise: $1.80Exp: 2035-03-01→ Common Stock (112,339 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0002057918
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:11 PM ET
- Size
- 6.7 KB